AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection

Aksyuk, A. A., Bansal, H., Wilkins, D., Stanley, A. M., Sproule, S., Maaske, J., Sanikommui, S., Hartman, W. R., Sobieszczyk, M. E., Falsey, A. R., & Kelly, E. J. (2023). AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection. Cell Reports Medicine, 4(1), 100882. https://doi.org/10.1016/j.xcrm.2022.100882
Authors:
Anastasia A Aksyuk
Himanshu Bansal
Deidre Wilkins
Ann Marie Stanley
Stephanie Sproule
Jill Maaske
Satya Sanikommui
William R Hartman
Magdalena E Sobieszczyk
Ann R Falsey
Elizabeth J Kelly
Affiliated Authors:
Magdalena E Sobieszczyk
Subjects:
COVID-19 (MeSH)
Author Keywords:
azd1222
breakthrough infection
chadox1 ncov-19
covid-19 vaccine
immunoassay
mucosal immune response
nasal antibody
nasal mucosal immunity
sars-cov-2 spike antibodies
serology
Publication Type:
Article
Unique ID:
10.1016/j.xcrm.2022.100882
PMID:
Publication Date:
Data Source:
PubMed

Record Created: